Zika Fever (Acute) – A Complete Medical Guide

Overview

Zika fever, also called acute Zika virus infection, is a short‑term illness caused by the Zika virus, a mosquito‑borne flavivirus closely related to dengue, yellow fever, and West Nile virus. The disease is usually mild and self‑limiting, lasting from a few days up to a week, but it can have serious implications for pregnant women and their fetuses.

Who it affects: Anyone bitten by an infected Aedes mosquito can become infected. The virus also spreads through sexual contact, blood transfusion, and from mother to fetus. Adults ages 18‑45 are most frequently reported in outbreak data, but children and older adults can be infected as well.

Prevalence: Since the first large outbreak on the Pacific island of Yap in 2007, Zika has spread across the Americas, Southeast Asia, and parts of Africa. The World Health Organization (WHO) estimates that between 2015‑2019 there were > 500,000 confirmed cases in the Americas alone, with the highest incidence in Brazil (≈ 150,000 cases) and Colombia (≈ 100,000 cases) ¹. In 2022 the U.S. Centers for Disease Control and Prevention (CDC) recorded 1,432 travel‑related Zika cases, indicating continued risk for travelers to endemic regions ².

Symptoms

Acute Zika infection is often asymptomatic (≈ 80% of cases). When symptoms occur, they typically appear 2‑14 days after exposure and last 2‑7 days. Common and less common manifestations are listed below.

• Fever – low‑grade (usually 37.5‑38.5 °C or 99.5‑101.5 °F).
• Maculopapular rash – often begins on the face and spreads to trunk and limbs; it can be itchy.
• Conjunctivitis (red eyes) – non‑purulent, without discharge.
• Arthralgia – joint pain, especially in hands and feet; may be migratory.
• Myalgia – muscle aches, similar to dengue.
• Headache – often mild to moderate, sometimes behind the eyes.
• Fatigue – a lingering sense of tiredness after other symptoms resolve.
• Gastrointestinal symptoms – occasional nausea, vomiting, or abdominal pain.
• Retro‑orbital pain – aching behind the eyes; less common than in dengue.

Symptoms are generally mild and do not require hospitalization. However, in pregnant women the infection is a red flag because of the risk of congenital Zika syndrome.

Causes and Risk Factors

What causes acute Zika fever?

The Zika virus (ZIKV) is transmitted primarily by the daytime‑biting Aedes aegypti and Aedes albopictus mosquitoes. The virus circulates in a cycle involving humans and mosquitoes, with occasional spillover to other animals (e.g., primates).

Risk factors for infection

• Living or traveling to endemic areas – most of Central and South America, Caribbean islands, parts of Southeast Asia, and some African regions.
• Outdoor exposure during daylight hours – Aedes mosquitoes are most active early morning and late afternoon.
• Sexual activity with an infected partner – Zika can be present in semen for up to 6 months.
• Pregnancy – pregnant women are advised to avoid travel to outbreak areas because of fetal risk.
• Blood transfusion or organ transplantation – rare but documented cases.
• Lack of vector control – environments with standing water, inadequate waste management, and dense housing increase mosquito breeding.

Diagnosis

Diagnosing acute Zika fever relies on a combination of clinical suspicion, travel history, and laboratory testing.

1. Clinical assessment

• Recent travel (within 2 weeks) to a Zika‑endemic region or known exposure to a confirmed case.
• Presence of characteristic rash, conjunctivitis, and arthralgia.
• Exclusion of other arboviruses (dengue, chikungunya) that cause overlapping symptoms.

2. Laboratory tests

1. Reverse transcription polymerase chain reaction (RT‑PCR) – detects viral RNA in serum, urine, or saliva. Most reliable within the first 7‑10 days of symptom onset.
2. Serology (IgM ELISA) – identifies Zika‑specific IgM antibodies; useful after the first week but can cross‑react with other flaviviruses. Confirmatory plaque reduction neutralization test (PRNT) may be required.
3. Urine testing – Zika RNA can persist longer in urine (up to 14 days) than in blood.

Pregnant women with suspected infection should receive both RT‑PCR (if within the acute window) and serology, followed by serial ultrasounds to monitor fetal development.

Treatment Options

There is no specific antiviral therapy for Zika. Management focuses on symptomatic relief and supportive care.

• Fever and pain control – acetaminophen (paracetamol) is preferred; avoid non‑steroidal anti‑inflammatory drugs (NSAIDs) until dengue is ruled out because of bleeding risk.
• Hydration – oral rehydration solutions or increased fluid intake to prevent dehydration from fever.
• Rest – adequate sleep supports immune clearance.
• Topical antihistamines or calamine lotion – alleviate itching from rash.
• Monitoring during pregnancy – regular obstetric visits, fetal ultrasound, and possibly amniocentesis if indicated.

Experimental treatments (e.g., monoclonal antibodies, antiviral nucleoside analogues) are under investigation but not yet approved for clinical use.

Living with Zika fever (acute)

Even though most people recover fully, certain daily practices can speed recovery and reduce the chance of transmission.

Symptom management

• Take acetaminophen 500‑1000 mg every 6‑8 hours as needed, not exceeding 3 g per day.
• Apply cool compresses to the forehead and rash area to lower temperature and relieve itch.
• Stay in an air‑conditioned or well‑ventilated room; avoid excessive heat.
• Consume soups, electrolyte drinks, and fruits to maintain fluid balance.
• Limit physical activity until fever and joint pain resolve.

Preventing spread to others

• Use condoms or abstain from sex for at least 6 months after symptom onset (or until a negative semen test) to avoid sexual transmission.
• Wash hands frequently, especially after using the bathroom.
• Avoid donating blood, plasma, or tissue for at least 28 days after recovery (CDC guideline).

Prevention

Because no vaccine is currently licensed, prevention hinges on vector control and personal protective measures.

Mosquito‑bite avoidance

• Wear long sleeves, long pants, and socks when outdoors.
• Apply EPA‑registered insect repellents containing DEET (≤30 %), picaridin, IR3535, or oil of lemon eucalyptus.
• Use permethrin‑treated clothing and gear.
• Stay in air‑conditioned rooms or use screened windows and doors.
• Sleep under insecticide‑treated bed nets if air‑conditioning is unavailable.

Environmental control

• Eliminate standing water in flower pots, buckets, old tires, and gutters at least weekly.
• Participate in community clean‑up campaigns.
• If possible, use larvicidal agents (e.g., Bacillus thuringiensis israelensis) in water containers.

Sexual transmission prevention

• Condom use for all sexual encounters for at least 3 months after symptom onset (or longer for men, per CDC).
• Testing of semen for Zika RNA in men planning to conceive.

Pregnancy‑specific advice

• Women who are pregnant or planning pregnancy should avoid travel to areas with ongoing Zika transmission (CDC Travel Health Notice).
• If travel is unavoidable, follow strict mosquito‑bite prevention and consider pre‑travel counseling with an obstetrician.

Complications

While most cases are mild, several serious outcomes have been documented.

• Congenital Zika syndrome – microcephaly, brain calcifications, eye abnormalities, and severe neurodevelopmental delays in infants born to infected mothers. The CDC estimates a 5‑10% risk of birth defects when infection occurs in the first trimester ³.
• Guillain‑Barré syndrome (GBS) – an autoimmune neuropathy causing muscle weakness and, in rare cases, paralysis. Meta‑analysis shows a 2‑4‑fold increased risk of GBS during Zika outbreaks ⁴.
• Persistent viral shedding – Zika RNA may be detectable in semen for up to 6 months, prolonging the window for sexual transmission.
• Severe thrombocytopenia or hemorrhagic manifestations – uncommon but reported, especially in co‑infection with dengue.

When to Seek Emergency Care

References

1. World Health Organization. Zika virus and complications: Fact sheet. Updated 2023.
2. Centers for Disease Control and Prevention. Travel-Related Zika Cases – United States, 2022. MMWR 2023;72:1‑8.
3. CDC. Zika Virus – Pregnancy Registry and Outcomes. Accessed May 2024. https://www.cdc.gov/zika/pregnancy
4. Rodriguez-Morales AJ, et al. Guillain‑Barré syndrome associated with Zika virus infection: Systematic review and meta‑analysis. J Neurol Sci. 2022; 434:119‑124.
5. Mayo Clinic. Zika virus infection. Accessed April 2024. https://www.mayoclinic.org